Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06445023
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-31
Brief Title:
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics